• Remote Monitoring for Ambulatory Care of Elderly Patients With Cancer

  NCT04913259

  Active, not recruitingInterventionalNot ApplicableUpdated Mar 3, 2026
• Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer

  NCT00873600

  WithdrawnObservationalUpdated Mar 19, 2015
• Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies

  NCT00973440

  CompletedObservationalUpdated Oct 22, 2013
• Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment

  NCT02619045

  CompletedInterventionalNot ApplicableUpdated Mar 2, 2018
• Feasibility of a Process of Digital Validation of Chemotherapies in a Day Treatment Unit

  NCT03977766

  Unknown statusInterventionalNot ApplicableUpdated Jun 6, 2019
• Oncogeriatric Intervention and Follow-up at Home

  NCT02837679

  Unknown statusInterventionalNot ApplicableUpdated Apr 29, 2020

ClinicalTrials.gov ID

NCT03959774

Lead Sponsor

Institut Paoli-CalmettesOTHER

Overall Status

Unknown status

Study Type

Interventional

Phase

Not Applicable

Enrollment

119Estimated

Last Update Posted

Jul 28, 2020Actual

Start Date

Dec 30, 2020Estimated

Primary Completion Date

Dec 30, 2022Estimated

Completion Date

Dec 30, 2023Estimated

Official Title

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment

Brief Summary

adherence of digital follow-up in a population of elderly patients.

Detailed Description

The use of digital self-questionnaires adapted to elderly patients but also to BrC and Bac could detect the toxicities of chemotherapy and we formulate the hypothesis that the continuous monitoring of these different variables in elderly patients treated with chemotherapy is possible and acceptable to this population.

• Breast Cancer
• Colorectal Cancer
• Lung Cancer

• IPC NET

Ages Eligible for Study

Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

1. Age ≥ 70 years,

2. Patient with an indication of adjuvant chemotherapy showing:

   • Breast cancer
   • Colorectal cancer
   • lung cancer

4. WHO ≤ 3 (WHO index - World Health Organization) 5. Estimated life expectancy> 6 months 6. patients with a smartphone or tablet with an internet connection. It can also be offered to patients whose primary caregiver or the person of trust (including the partner) has a smartphone, an internet connection or a tablet provided that he or she is present more than three times during the week. during chemotherapy to ensure smooth weekly data transfer and filling of questionnaires 7. Signed consent to participation 8. Affiliation to, or beneficiary of, a social security scheme

Exclusion Criteria:

1. Person in emergency situation, person of legal age subject to a legal protection measure (major under guardianship, guardianship or court order), or unable to express his / her consent
2. Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons
3. Contraindications to the procedure of the study: patient or caregiver living with a patient who does not have a smartphone with an internet connection (patient or caregiver living with a patient)
4. Concurrent participation in another clinical trial
5. Patient unable to understand the quality of life survey and Patient Reported Outcome

Primary Purpose

Supportive Care

Allocation

N/A

Interventional Model

Single Group Assignment

Masking

None (Open Label)

Lead Sponsor

Institut Paoli-CalmettesOTHER

drci.up@ipc.unicancer.fr33(0) 4 91 22 37 78